Quince Therapeutics Inc Share Price Today (NASDAQ: QNCX)

Name: Quince Therapeutics Inc Share Price (NASDAQ: QNCX) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Quince Therapeutics Inc share price is 0.86 & ₹73.65 as on 17 May 2025, 2.30 'hrs' IST

$0.86

▲

0.02

(2.5%)

Market is closed - opens 7 PM, 19 May 2025

View live Quince Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Quince Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Quince Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Quince Therapeutics Inc share price movements

Today's Low: $0.82
Today's High: $0.86
$0.86
4.52%
Downside
Day's Volatility :4.98%
Upside
0.47%
52 Weeks Low: $0.51
52 Weeks High: $2.45
$0.86
40.51%
Downside
52 Weeks Volatility :79.12%
Upside
64.9%

Quince Therapeutics Inc (QNCX) Returns

Period	Quince Therapeutics Inc	Index (Russel 2000)
3 Months	-39.01%	0.0%
6 Months	-50.86%	0.0%
1 Year	-4.42%	0.0%
3 Years	-72.26%	-0.4%

Quince Therapeutics Inc (QNCX) Key Statistics

in dollars & INR

Previous Close	$0.839
Open	$0.8211
Today's High	$0.8641
Today's Low	$0.8211
Market Capitalization	$38.6M
Today's Volume	$98.8K
52 Week High	$2.45
52 Week Low	$0.5116
Revenue TTM	$0.0
EBITDA	$-37.8M
Earnings Per Share (EPS)	$-1.39
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-130.9%

How to invest in Quince Therapeutics Inc Stock (QNCX) from India?

It is very easy for Indian residents to invest directly in Quince Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quince Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Quince Therapeutics Inc or QNCX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quince Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quince Therapeutics Inc shares which would translate to 0.996 fractional shares of Quince Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Quince Therapeutics Inc, in just a few clicks!

Returns in Quince Therapeutics Inc (QNCX) for Indian investors in Rupees

The Quince Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Quince Therapeutics Inc investment value today

Current value as on today

₹98,287

Returns

₹1,713

(-1.71%)

Returns from Quince Therapeutics Inc Stock

₹4,444 (-4.44%)

Dollar Returns

₹2,731 (+2.73%)

Indian investors sentiment towards Quince Therapeutics Inc (QNCX)

100%

Period: Apr 18, 2025 to May 18, 2025. Change in 30 Days versus previous period

Search interest for Quince Therapeutics Inc Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Quince Therapeutics Inc

Vanguard Group Inc
2.91%
EPIQ Capital Group, LLC
1.87%
Renaissance Technologies Corp
1.13%
Geode Capital Management, LLC
0.85%
BlackRock Inc
0.78%
HighTower Advisors, LLC
0.77%

Analyst Recommendation on Quince Therapeutics Inc

Rating

Trend

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Quince Therapeutics Inc(by analysts ranked 0 to 5 stars)

Insights on QNCX Stock (Ticker Symbol: QNCX)

Price Movement
In the last 7 days, QNCX stock has moved down by -16.5%
QNCX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 90.9% return, outperforming this stock by 95.9%
QNCX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.4% return, outperforming this stock by 194.3%

Quince Therapeutics Inc (QNCX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quince Therapeutics Inc	-18.1%	-50.86%	-4.42%	-72.26%	-98.48%
Regeneron Pharmaceuticals, Inc.	5.81%	-22.03%	-39.82%	-10.14%	2.98%
Beone Medicines Ltd	-0.51%	21.5%	30.82%	66.06%	37.54%
Vertex Pharmaceuticals Incorporated	-8.14%	-6.07%	-1.62%	69.63%	54.11%
Alnylam Pharmaceuticals, Inc.	22.5%	22.76%	89.78%	115.57%	98.77%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quince Therapeutics Inc	NA	NA	NA	-0.61	-1.31	-0.18	NA	0.42
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.26	35.5	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.5	-0.11	-0.03	NA	32.42
Vertex Pharmaceuticals Incorporated	32.84	NA	2.59	18.0	-0.06	0.12	NA	64.2
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.06	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quince Therapeutics Inc	Sell	$38.6M	-98.48%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$63.2B	2.98%	14.86	31.94%
Beone Medicines Ltd	NA	$26.3B	37.54%	NA	-9.4%
Vertex Pharmaceuticals Incorporated	Buy	$111.5B	54.11%	32.84	-8.91%
Alnylam Pharmaceuticals, Inc.	Buy	$34.9B	98.77%	NA	-11.49%

About Quince Therapeutics Inc

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Organization	Quince Therapeutics Inc
Employees	36
CEO	Dr. Dirk Thye M.D.
Industry	Healthcare

Management People of Quince Therapeutics Inc

Name	Title
Dr. Dirk Thye M.D.	CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.	President
Mr. Brendan Hannah M.B.A.	Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Mr. Giovanni Mambrini M.Sc.	Chief Technology Officer
Dr. Guenter R. Janhofer M.D., Ph.D.	Chief Scientific Officer
Ms. Stacy Roughan	Vice President of Corporate Communications & Investor Relations
Ms. Mary Ellen Sillivos	Vice President of Human Resources
Dr. Stewart A. Low Ph.D.	Head of Discovery
Ms. Pamela M. Williamson FRAPS, M.B.A., RAC	Head of Regulatory Affairs

Important FAQs about investing in QNCX Stock from India :

Can Indians buy Quince Therapeutics Inc shares?

Yes, Indians can invest in the Quince Therapeutics Inc (QNCX) from India.

With INDmoney, you can buy Quince Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Quince Therapeutics Inc at zero transaction cost.

How can I buy Quince Therapeutics Inc shares from India?

It is very easy to buy Quince Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quince Therapeutics Inc (QNCX) be purchased?

Yes, you can buy fractional shares of Quince Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Quince Therapeutics Inc stocks?

To start investing in Quince Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Quince Therapeutics Inc share price today?

Quince Therapeutics Inc share price today stands at $0.86, Open: $0.82 ; Previous Close: $0.84 ; High: $0.86 ; Low: $0.82 ; 52 Week High: $2.45 ; 52 Week Low: $0.51.

The stock opens at $0.82, after a previous close of $0.84. The stock reached a daily high of $0.86 and a low of $0.82, with a 52-week high of $2.45 and a 52-week low of $0.51.